Publication Cover
Redox Report
Communications in Free Radical Research
Volume 13, 2008 - Issue 4
89
Views
1
CrossRef citations to date
0
Altmetric
Research articles

The various impacts of the hepatitis C virus core protein upon hepatic oxidative stress after common bile duct ligation and partial hepatectomy

, , , , &
Pages 172-178 | Published online: 19 Jul 2013

References

  • Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002; 62 (Suppl 1): 29–37.
  • Hayashi J, Aoki H, Arakawa Y, Hino O. Hepatitis C virus and hepatocarcinogenesis. Intervirology 1999; 42: 205–210.
  • Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 2004; 127 (Suppl 1): S62–S71.
  • Koike K. Pathogenesis of HCV-associated HCC: dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling. Hepatol Res 2007; 37 (Suppl 2): S115–S120.
  • Korenaga M, Wang T, Li Y et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005; 280: 37481–37488.
  • Piccoli C, Scrima R, Quarato G et al. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 2007; 46: 58–65.
  • Moriya K, Nakagawa K, Santa T et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001; 61: 4365–4370.
  • Naas T, Ghorbani M, Alvarez-Maya I et al. Characterization of liver histopathology in a transgenic mouse model expressing genotype la hepatitis C virus core and envelope proteins 1 and 2. J Gen Viro12005; 86: 2185-2196.
  • Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis Cvirus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065–1067.
  • Portolani N, Coniglio A, Ghidoni S et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006; 243: 229–235.
  • Katz LH, Mor E, Brown M et al. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome. Clin Transplant 2006; 20: 465–470.
  • Kistner A, Gossen M, Zimmermann F et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933–10938.
  • Chang ML, Chen JC, Yeh CT et al. The topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice. World J Gastroenterol 2007; 13: 3472–3477.
  • Chang ML, Yeh CT, Chen JC et al. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics 2008; 9: 109.
  • Huerta JM, Gonzalez S, Fernandez S, Patterson AM, Lasheras C. Lipid peroxidation, antioxidant status and survival in institutionalised elderly: a five-year longitudinal study. Free Radic Res 2006; 40: 571–578.
  • Sureda A, Tauler P, Aguilo A et al. Relation between oxidative stress markers and antioxidant endogenous defences during exhaustive exercise. Free Radic Res 2005; 39: 1317–1324.
  • Petersen DR, Doom JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004; 37: 937–945.
  • Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 2001; 30: 421–455.
  • Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003; 16: 99–102.
  • Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 2001; 153: 1023–1034.
  • Shao J, Qiao L, Janssen RC, Pagliassotti M, Friedman JE. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 2005; 54: 976–984.
  • Kimmings AN, van Deventer SJ, Rauws EAJ, Huibregtse K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur J Surg 2000; 166: 700–705.
  • Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int. 2003; 23: 63–69.
  • Shimizu I, Inoue H, Yano Met al. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 2001; 21: 342–349.
  • Turanov AA, Su D, Gladyshev VN. Characterization of alternative cytosolic forms and cellular targets of mouse mitochondrial thioredoxin reductase. J Biol Chem 2006; 281: 22953–22963.
  • Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 2001; 30: 421–455.
  • Ohashi S, Nishio A, Nakamura H et al. Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. Am J Physiol 2006; 290: G772–G781.
  • Polat A, Emre MH. Effects of melatonin or acetylsalicylic acid on gastric oxidative stress after bile duct ligation in rats. J Gastroenterol 2006; 41: 433–439.
  • Alexandris IH, Assimakopoulos SF, Vagianos CE et al. Oxidative state in intestine and liver after partial hepatectomy in rats. Effect of bombesin and neurotensin. Clin Biochem 2004; 37: 350–356.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.